Compare CNTA & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTA | NMIH |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2021 | 2013 |
| Metric | CNTA | NMIH |
|---|---|---|
| Price | $27.60 | $37.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $40.89 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.1M | 371.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.06 |
| EPS | N/A | ★ 4.92 |
| Revenue | N/A | ★ $706,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.34 |
| P/E Ratio | ★ N/A | $7.53 |
| Revenue Growth | N/A | ★ 8.52 |
| 52 Week Low | $9.60 | $32.71 |
| 52 Week High | $30.58 | $43.20 |
| Indicator | CNTA | NMIH |
|---|---|---|
| Relative Strength Index (RSI) | 62.15 | 36.16 |
| Support Level | $21.93 | $36.78 |
| Resistance Level | $27.56 | $37.66 |
| Average True Range (ATR) | 1.18 | 0.77 |
| MACD | 0.14 | -0.26 |
| Stochastic Oscillator | 71.59 | 23.45 |
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.